E. Coli Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

E. Coli Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


Market Overview 2023-2028:

The global E. coli testing market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 7.65% during 2023-2028.

Escherichia coli (E. Coli) testing refers to the process of detecting and monitoring the presence of foodborne pathogens. E. Coli bacteria is usually found in contaminated food and water, cheese manufactured from raw milk, undercooked products, unpasteurized milk and raw fruits and vegetables. It can cause various diseases, such as food poisoning, pneumonia and urinary tract infections (UTIs). Some of the clinical testing methods for the detection of E. Coli include enzyme immunoassays (EIA) and polymerase chain reaction (PCR) tests, along with environmental testing methods, such as enzyme-substrate, membrane filtration and multiple tube fermentation (MTF). These techniques aid in obtaining an accurate and quantitative measure of total coliform and bacteria present in the sample.

The increasing prevalence of water-borne diseases, such as diarrhea and hemolytic uremic syndrome (HUS), along with the growing need for clean potable water across the globe, is one of the key factors creating a positive outlook for the market. E. Coli tests can aid in monitoring the quality of surface and drinking water to prevent the spread of illnesses and diseases. Furthermore, the widespread adoption of the enzyme-substrate test as a presence or absence (P/A) test is also driving the market growth. These tests are easy to perform, do not require sophisticated laboratory equipment and use hydrolyzable fluorogenic substrates to detect the presence of various enzymes produced by the bacteria. Additionally, various technological advancements, such as the development of innovative bacterial diagnostic instruments and water testing methods, are contributing to the market growth. Other factors, including increasing health consciousness among the masses, along with extensive research and development (R&D) activities in the field of microbiology, are expected to drive the market further.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global E. coli testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, test type and end user.

Breakup by Product:

Consumables
Instruments

Breakup by Test Type:

Environmental Test
Membrane Filtration (MF)
Multiple Tube Fermentation (MTF)
Enzyme Substrate Methods
Clinical Test
Polymerase Chain Reaction (PCR) Tests
Enzyme Immunoassays (EIA)
Others

Breakup by End User:

Hospitals and Clinics
Diagnostic Laboratories
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Accugen Laboratories Inc., Alere Inc. (Abbott Laboratories), BD (Becton Dickinson and Company), bioMérieux (INSTITUT MERIEUX), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc. (Enzo Biochem Inc.), Idexx Laboratories Inc., Johnson & Johnson, Meridian Bioscience Inc., Nanologix Inc., Pro-Lab Diagnostics, Qiagen N.V. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:
How has the global E. coli testing market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global E. coli testing market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the test type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global E. coli testing market and who are the key players?
What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global E. Coli Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Consumables
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Test Type
7.1 Environmental Test
7.1.1 Market Trends
7.1.2 Major Types
7.1.2.1 Membrane Filtration (MF)
7.1.2.2 Multiple Tube Fermentation (MTF)
7.1.2.3 Enzyme Substrate Methods
7.1.3 Market Forecast
7.2 Clinical Test
7.2.1 Market Trends
7.2.2 Major Types
7.2.2.1 Polymerase Chain Reaction (PCR) Tests
7.2.2.2 Enzyme Immunoassays (EIA)
7.2.2.3 Others
7.2.3 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostic Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Accugen Laboratories Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Alere Inc. (Abbott Laboratories)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 BD (Becton Dickinson and Company)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 bioMérieux (INSTITUT MERIEUX)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Bio-RAD Laboratories Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Enzo Life Sciences Inc. (Enzo Biochem Inc.)
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Idexx Laboratories Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Johnson & Johnson
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Meridian Bioscience Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Nanologix Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Pro-Lab Diagnostics
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Qiagen N.V.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13 Thermo Fisher Scientific Inc.
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings